Navigation Links
Triclosan in cosmetics and personal care products can increase allergy risk
Date:11/14/2012

Triclosan - an antibacterial chemical found in toothpaste and other products - can contribute to an increased risk of allergy development in children. This comes from the Norwegian Environment and Childhood Asthma Study, in which the Norwegian Institute of Public Health is involved. Similar results are reported in the USA.

Triclosan has been in use for decades, but was recently associated with allergies in children in an American study, the National Health and Nutrition Examination Survey (NHANES). The new Norwegian study found similar associations between allergies and triclosan levels measured in children's urine.

The study found that triclosan levels measured in urine were associated with elevated levels of Immunoglobulin E (IgE) and rhinitis (blocked nose/hay fever) in 10 year-olds.

623 urine samples were collected and measured at the Center for Disease Control and Prevention in Atlanta, USA. Approximately 50 per cent of the Norwegian children had detectable levels of triclosan, while 80 per cent of American children had measurable levels. The children had approximately the same amount of triclosan exposure.

Triclosan can change the bacterial flora on the skin, in the mouth and in the intestines. A change in the bacterial composition of "good" bacteria can cause an increased risk of developing allergies (hygiene hypothesis). Therefore, increased use of triclosan and antibacterial products has generally been associated with an increased incidence of allergies.

Reduce consumption

For many years, the health authorities in Norway have called for a reduction in the use of antibacterial products to prevent the development of resistant bacteria.

In a study of triclosan use in Norway in 2001, it was found that 85 per cent of the total amount of triclosan came from cosmetic products, of which 75 per cent were toothpaste. Since this study, triclosan has been removed from a variety of products.

The extent to which Norwegian children are exposed to triclosan is today uncertain. In the USA, where they have annual sampling and monitoring of chemical exposure, there is little evidence that exposure to triclosan is being reduced.


'/>"/>

Contact: Julie Johansen
julie.johansen@fhi.no
Norwegian Institute of Public Health
Source:Eurekalert

Related biology news :

1. Triclosan needs to be monitored
2. China poised to accept first-ever non-animal test method for cosmetics
3. Privately owned genetic databases may hinder diagnosis and bar the way to the arrival of personalized medicine
4. How to Differentiate Your Pharmaceutical Product in the Personalized Medicine Segment
5. In elk hunting, success depends on the animals personality
6. Creating a future of personalized medicine: U-M forms joint venture for DNA diagnostics
7. Antimicrobials from personal care products found in statewide survey of Minnesotas rivers and lakes
8. Chromosomal translocations point the way toward personalized cancer care
9. Personality genes may help account for longevity
10. Advances in personalized medicine for lung cancer
11. Friendly to a fault, yet tense: Personality traits traced in brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
Breaking Biology Technology: